SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 1/30/23 GE HealthCare Technologies Inc. 8-K:2,9 1/30/23 11:1.8M |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 40K 2: EX-99 Miscellaneous Exhibit HTML 471K 6: R1 Cover Page HTML 45K 9: XML IDEA XML File -- Filing Summary XML 11K 7: XML XBRL Instance -- gehc-20230130_htm XML 23K 8: EXCEL IDEA Workbook of Financial Reports XLSX 8K 4: EX-101.LAB XBRL Labels -- gehc-20230130_lab XML 67K 5: EX-101.PRE XBRL Presentations -- gehc-20230130_pre XML 33K 3: EX-101.SCH XBRL Schema -- gehc-20230130 XSD 10K 10: JSON XBRL Instance as JSON Data -- MetaLinks 12± 17K 11: ZIP XBRL Zipped Folder -- 0001932393-23-000007-xbrl Zip 51K
gehc-20230130 |
i Delaware | i 001-41528 | i 88-2515116 | |||||||||||||||||||||
(State
or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | |||||||||||||||||||||
i 500 W. Monroe Street | i Chicago, | i IL | i 60661 | ||||||||||||||||||||
(Address of principal executive offices) | (Zip Code) | ||||||||||||||||||||||
i ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||||
i ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||||
i ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||||
i ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title
of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
i Common stock, par value $0.01 per share | i GEHC | i The
Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). | ||||||||
Emerging growth company | i ☐ | |||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. | ☐ |
Exhibit | Description | ||||
99 | |||||
104 | The cover page of this Current Report on Form 8-K, formatted in Inline XBRL. |
GE HealthCare Technologies Inc. | ||||||||
(Registrant) | ||||||||
| ||||||||
Date:
i January 30, 2023 | /s/ George A. Newcomb | |||||||
George A. Newcomb, Chief Accounting Officer (authorized signatory) |
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period end: | 1/30/23 | None on these Dates | ||
12/31/22 | ||||
List all Filings |